GlassScriptPhysician profile
Kevin Dux
NPI 1780901694
$7,542.66
in general payments reported to CMS, 2019-2025
23 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,029 · 2020: $555 · 2021: $1,217 · 2022: $1,645 · 2023: $2,104 · 2024: $354 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,146 · Travel and Lodging: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,146.18 |
| Travel and Lodging | $950.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,656.22 | 2019-2025 | Salvation, Augment Injectable, Prostep |
| Smith+Nephew, INC. | $1,377.44 | 2019-2025 | Collagenase Santyl |
| Pylant Medical | $1,302.21 | 2022-2024 | |
| Integra Lifesciences Corporation | $232.80 | 2023 | Tenoglide |
| Medline Industries LP | $161.12 | 2025 | |
| Next Science LLC | $116.79 | 2022-2023 | Surgx, Blastx, Xperience |
| Organogenesis INC. | $114.72 | 2019-2025 | Puraply, Cygnus Dual |
| Tenex Health INC. | $106.97 | 2020 | |
| Depuy Synthes Sales INC. | $55.24 | 2022-2025 | Motoband |
| Zyla Life Sciences, INC. | $52.23 | 2019-2020 | |
| Kci USA, INC. | $49.58 | 2019 | |
| Biocomposites INC | $43.65 | 2024-2025 | Stimulan |
| Polynovo North America LLC | $42.70 | 2024-2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $38.49 | 2021-2024 | Nuzyra |
| Bioventus LLC | $30.86 | 2022-2025 | Exogen Ultrasound Bone Healing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $29.53 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.09 | 2022 | |
| Kerecis Limited | $22.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Amgen INC. | $21.98 | 2025 | Krystexxa |
| Innovation Technologies INC | $18.90 | 2021 | |
| Ossio INC | $17.38 | 2023 | |
| Horizon Therapeutics Plc | $14.42 | 2023 | Krystexxa |
| Convatec INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Dux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.